GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » 1933 Industries Inc (OTCPK:TGIFF) » Definitions » Debt-to-Revenue

1933 Industries (1933 Industries) Debt-to-Revenue : 0.87 (As of Jan. 2024)


View and export this data going back to . Start your Free Trial

What is 1933 Industries Debt-to-Revenue?

Debt-to-Revenue measures a company's ability to pay off its debt.

1933 Industries's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Jan. 2024 was $0.44 Mil. 1933 Industries's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Jan. 2024 was $11.86 Mil. 1933 Industries's annualized Revenue for the quarter that ended in Jan. 2024 was $14.14 Mil. 1933 Industries's annualized Debt-to-Revenue for the quarter that ended in Jan. 2024 was 0.87.


1933 Industries Debt-to-Revenue Historical Data

The historical data trend for 1933 Industries's Debt-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

1933 Industries Debt-to-Revenue Chart

1933 Industries Annual Data
Trend Dec14 Jul15 Jul16 Jul17 Jul18 Jul19 Jul20 Jul21 Jul22 Jul23
Debt-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.27 2.15 1.49 1.41 0.96

1933 Industries Quarterly Data
Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24
Debt-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.05 1.11 0.89 0.83 0.87

Competitive Comparison of 1933 Industries's Debt-to-Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, 1933 Industries's Debt-to-Revenue, along with its competitors' market caps and Debt-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


1933 Industries's Debt-to-Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, 1933 Industries's Debt-to-Revenue distribution charts can be found below:

* The bar in red indicates where 1933 Industries's Debt-to-Revenue falls into.



1933 Industries Debt-to-Revenue Calculation

Debt-to-Revenue measures a company's ability to pay off its debt.

1933 Industries's Debt-to-Revenue for the fiscal year that ended in Jul. 2023 is calculated as

Debt-to-Revenue=Total Debt / Revenue
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Revenue
=(3.782 + 9.519) / 13.832
=0.96

1933 Industries's annualized Debt-to-Revenue for the quarter that ended in Jan. 2024 is calculated as

Debt-to-Revenue=Total Debt / Revenue
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Revenue
=(0.437 + 11.862) / 14.14
=0.87

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-Revenue, the Revenue of the last fiscal year is used. In calculating the annualized quarterly data, the Revenue data used here is four times the quarterly (Jan. 2024) Revenue data.


1933 Industries Debt-to-Revenue Related Terms

Thank you for viewing the detailed overview of 1933 Industries's Debt-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


1933 Industries (1933 Industries) Business Description

Traded in Other Exchanges
Address
1055 West Hastings Street, Suite 300, Vancouver, BC, CAN, V6E 2E9
1933 Industries Inc is a vertically integrated cannabis company. The company is focused on the cultivation and manufacturing of cannabis consumer-branded goods. The Company operates in three segments, referred to as AMA, Infused MFG, and Corporate. AMA is focused on the cultivation and sale of medical and adult-use cannabis products, and Infused MFG is focused on the manufacturing of hemp-derived CBD products. The majority of revenue is generated from the AMA segment. The operations of AMA and Infused MFG are located in the United States. All revenues are earned in the United States.